We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OOMA:NYSEOoma, Inc. Analysis

Data as of 2026-06-14 - not real-time

$17.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Ooma’s price is trading above its short‑term moving average while staying above the 50‑day trend line, signaling a bullish alignment despite a recent bearish MACD crossover that hints at short‑term momentum weakness. Volume remains stable and the RSI hovers around the midpoint, suggesting neither overbought nor oversold conditions. The stock sits comfortably above a key support zone, providing a cushion against further downside. Recent product recognition for Ooma AirDial reinforces its competitive positioning in the POTS replacement market, and the company’s roadmap emphasizes AI‑driven expansion. Forward earnings estimates have improved dramatically, and the discounted cash‑flow model points to a valuation substantially higher than the current market price, implying a material upside potential.
However, the equity exhibits elevated short‑term volatility and a modest beta, reflecting sensitivity to market swings. The balance sheet shows a moderate debt load relative to equity, and cash flow generation remains healthy, supporting ongoing investment. Investor interest is evident from multiple upcoming conference appearances, which could catalyze further price appreciation. Overall, the blend of technical bullishness, strong growth fundamentals, and a compelling valuation gap makes Ooma an attractive candidate for investors with a medium‑to‑long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish placement above short‑term moving averages
  • Bearish MACD histogram indicating potential near‑term pullback
  • Stable volume and support level providing downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and accelerating forward EPS
  • DCF‑derived fair value far above current price suggesting upside
  • Product award and AI expansion fueling market share gains

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained cash flow generation supporting reinvestment
  • Undervalued relative to peers with a high growth trajectory
  • Long‑term tailwinds in UCaaS and AI‑enabled communications

Key Metrics & Analysis

Financial Health

Revenue Growth24.80%
Profit Margin3.17%
P/E Ratio53.2
ROE10.00%
ROA3.04%
Debt/Equity70.82
P/B Ratio5.0
Op. Cash Flow$30.4M
Free Cash Flow$35.6M
Industry P/E36.8

Technical Analysis

TrendBullish
RSI49.8
Support$16.25
Resistance$21.96
MA 20$18.02
MA 50$17.02
MA 200$13.34
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$44.74
Target Price$23.00
Upside/Downside31.05%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.88
Volatility51.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.